ADIPOQ and type 2 diabetes mellitus: The main findings of this review were that, compared to the WM control group, CDDP or CDDP + WM treatment in patients with T2DM resulted in significantly lower LSR, HSR, PV, and hemorheologic factors, such as homocysteine and adiponectin.